>

Adult male (stage III subcutaneous obesity)

Q: Can I use the Adult male (stage III subcutaneous obesity) icon in a BioRender figure or scientific illustration?

Yes — the Adult male (stage III subcutaneous obesity) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the Adult male (stage III subcutaneous obesity) icon for publication or presentations?

Yes — figures containing the Adult male (stage III subcutaneous obesity) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Adult male (stage III subcutaneous obesity) - Editable icon of An adult male with stage III subcutaneous obesity, viewed from the anterior front side in anatomical position

[{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e343/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e343/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e344/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e344/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e345/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e345/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e346/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e346/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e347/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e347/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e348/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e348/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e349/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e349/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e34a/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e34a/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e34b/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e34b/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e34c/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e34c/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e34d/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e34d/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e34e/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e34e/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e34f/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e34f/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e350/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e350/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e351/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e351/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e352/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e352/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e353/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e353/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e354/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e354/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e355/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e355/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e356/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e356/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e357/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e357/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e358/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e358/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e359/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e359/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e35a/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e35a/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e35b/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e35b/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e35c/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e35c/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e35d/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e35d/663cddce2503f75db368e305.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/663cde072503f75db368e35e/663cddce2503f75db368e305.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/663cde072503f75db368e35e/663cddce2503f75db368e305.png"}]

Keywords

keyword text

male obesity,obese male,obese man,stage III obesity,stage 3 obesity,stage III,subcutaneous obesity,visceral obesity,central obesity,fat male,fat man,overweight male,overweight man,overweight,body mass index,high BMI,BMI,fat,obesity,obese,chubby,large size,fatness,II,insulin,diabetes,hypertension,adult male,human body man,person,body,people,figure,male,man,boy,guy,face,eyes open,hair,standing,stand,stood,back,head,limbs,arm,leg,hand,foot,feet,adult,mature,grown,full-grown,young adult,middle adult,old adult,anterior,frontal,front view,anterior view,front,anatomical position,nude,naked,without clothes,unclothed,obese,obesity,overweight,fat

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Adult male (stage III subcutaneous obesity) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Adult male (stage III subcutaneous obesity) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Adult male (stage III subcutaneous obesity) icon customizable in BioRender?

Most icons in BioRender, including the Adult male (stage III subcutaneous obesity) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Adult male (stage III subcutaneous obesity) icon in their work?

BioRender users often use the Adult male (stage III subcutaneous obesity) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Can I export figures that include the Adult male (stage III subcutaneous obesity) icon for publication or presentations?

Yes, figures containing the Adult male (stage III subcutaneous obesity) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Adult male (stage III subcutaneous obesity) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Adult male (stage III subcutaneous obesity) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

Adult male (stage III subcutaneous obesity)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?